The New Urgency Of Data Intelligence Access
The final day narrative of the inaugural Anju Innovation Forum was essentially "time is of the essence" combined with a new focus on adaptive and versatile data access and data interpretation solutions. Speed to data without sacrificing quality of data is absolutely critical for continuing to bringing the most promising future therapies to patients and their care providers. While the COVID pandemic has absolutely been a major catalyst for shaking up the industry to seek a new urgency for understanding and appreciating the value of fast and customizable medical data access, new, smart data intelligence approaches to everything from accelerated ramp up of clinical trials to innovations in format and delivery of medical science content will be a permanent change, COVID or not, based on discussion threads in today's sessions. Pharma clients, trial sponsors and CROs confirmed these assertions in sessions throughout the day and also affirmed that Anju technology is at the forefront of being able to provide the most advanced solutions for giving them the data intelligence "edge" to get them post-COVID and beyond. Decentralized hybrid clinical trials and the elevation of the medical affairs function are just two of the outcomes of the advances of data intelligence technology, take-away themes of Anju Innovation Forum Day 3. Highlights of the data urgency access need include:
Day 3 ended with the same theme as it began - a speed and urgency for advances in Anju TrialMaster technology to implement fast trial design.
For more information about Anju events, contact firstname.lastname@example.org